Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 16 smoking PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


smoking PhD Projects, Programmes & Scholarships

We have 16 smoking PhD Projects, Programmes & Scholarships

Harnessing the genetics of DNA methylation to understand context-specific gene regulation in disease

Genome wide association studies (GWAS) have discovered many genetic associations for traits and diseases. However, most GWAS signals reside in non-coding regions (outside genes), and it is likely that GWAS variants confer their effects through modulating regulatory mechanism. Read more

Harnessing the genetics of DNA methylation to understand context-specific gene regulation in disease

Project Background. Genome wide association studies (GWAS) have discovered many genetic associations with health outcomes. However, most GWAS signals reside in non-coding regions and it is likely that GWAS variants confer their effects through a regulatory mechanism. Read more

Health PhD

As a PhD student in the Department for Health at Bath you will have the opportunity to undertake original, in-depth research under expert supervision working in one of the top rated research Universities in the UK. Read more
Last chance to apply

Data science and child health inequalities

We are excited to share this application for a 4-year PhD studentship based in the Division of Child Health, University of Liverpool, in conjunction with Alder Hey Children’s Hospital, Liverpool, and Imperial College London. Read more
Last chance to apply

What do effect sizes mean in real terms? Benchmarking effect sizes in behavioural research

A fully-funded studentship is available to work alongside the team working on the BR-UK project (https://www.linkedin.com/company/behavioural-research-uk/) at the University of Sheffield. Read more

Identifying cognitive and biochemical changes underlying lifestyle risk factors for dementia

  Research Group: Pharmacology and Experimental Therapeutics
Dementia describes a group of age-associated conditions of which cognitive decline is a major feature. Alzheimer’s disease (AD) is the most common cause of dementia and is characterised by the onset of a gradual cognitive decline. Read more

Cancer biology: identification of new treatment options for EML4-ALK driven lung cancer through understanding mechanisms of cell division and migration.

Lung cancer is the largest cause of cancer-related deaths in the UK and worldwide. While little progress has been made in long-term survival rates, we now have a good understanding of the genetic drivers raising the prospect of earlier diagnosis and more effective treatments. Read more

Identifying metabolic drivers of cancer development

Rationale. Growing evidence suggests that cell extrinsic factors are key in modulating tumor progression. Metabolites are small molecules that act as sources of fuel and building blocks essential for cells and tissues when present at normal levels. Read more

Identifying causal pathways to disease using DNA methylation predicted blood traits.

Project Background. Blood cell types have been implicated in pathogenesis of chronic diseases. Genome wide association studies have identified thousands of variants associated with blood trait variation. Read more

Untying the knot: Remodelling of G4 structures by the NER machinery- implications in human DNA repair and regulatory pathways

Open PhD position on Genome Stability and Biochemistry. Joint PhD scholarship - St Andrews and Bonn-Biology. Untying the knot. Remodelling of G4 structures by the NER machinery- implications in human DNA repair and regulatory pathways. Read more

Repurposing and enriching cardiovascular risk prediction model to identify people at risk of cancer – UCL (part of Health Data Research UK’s Big Data for Complex Disease Driver Programme)

Risk-stratified management of cardiovascular disease (CVD), where people without established disease receive preventative interventions and monitoring based on their 10-years predicted risk, has been highly successful to ensure healthcare resources are allocated to those most likely to benefit. Read more
  • 1

Filtering Results